Cite
HARVARD Citation
Leroy, V. et al. (n.d.). Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+). Hepatology. 63 (5), pp. 1430-1441. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Leroy, V. et al. (n.d.). Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY‐3+). Hepatology. 63 (5), pp. 1430-1441. [Online].